Skip to content
Pharma Observatory a Scientist.com platform

Organization (Other)

Silvia Ulrich Somaini

ClinicalTrials.gov lists Silvia Ulrich Somaini as lead sponsor of 17 trials.

Other
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Disease areas Disease areas 6 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 2 Sponsor delivery record Sponsor delivery record 1 Latest dated events Latest dated events 17 Disease areas Disease areas 6 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 2 Sponsor delivery record Sponsor delivery record 1 Latest dated events Latest dated events 17

Rows recorded per section

20 sections measured, none recorded

This page covers Silvia Ulrich Somaini: 17 lead-sponsored trials and 0 legal-entity registrations.

Get the Silvia Ulrich Somaini report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (6)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Altitude Sickness 14
Hypertension, Pulmonary 9
Hypoxia 9
Pulmonary Arterial Hypertension 9
Hypertension 7

Showing 5 of 6 disease areas.

Start your 14-day trial Email me all 6 disease areas as a PDF

Trials by start year as sponsor or collaborator (2)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 16
2025 1

No forecast is made for this organization: it averages 3.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 17 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

Sponsor delivery record (1)

Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.

Sponsor delivery record
Enrollment Timeline
0 of 1 hit target (n=1) 0 of 1 on time (n=1)

Latest dated events (17)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-10-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-10-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-09-25 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-09-25 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-09-25 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 17 events.

Start your 14-day trial Email me all 17 events as a PDF

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, approved assets, journals published in, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.